Cargando…

Plasma FGF21 concentrations are regulated by glucose independently of insulin and GLP-1 in lean, healthy humans

BACKGROUND: Fibroblast growth factor 21 (FGF21) treatment improves metabolic homeostasis in diverse species, including humans. Physiologically, plasma FGF21 levels increase modestly after glucose ingestion, but it is unclear whether this is mediated by glucose itself or due to a secondary effect of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Solomon, Thomas P.J., Carter, Steven, Haus, Jacob M., Karstoft, Kristian, von Holstein-Rathlou, Stephanie, Nielsen, Mette S., Gillum, Matthew P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2022
Materias:	Clinical Trials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783558/ https://www.ncbi.nlm.nih.gov/pubmed/35111398 http://dx.doi.org/10.7717/peerj.12755

Ejemplares similares

Transient postprandial increase in intact circulating fibroblast growth factor-21 levels after Roux-en-Y gastric bypass: a randomized controlled clinical trial
por: Nielsen, Mette S., et al.
Publicado: (2021)

Does FGF21 Mediate the Potential Decrease in Sweet Food Intake and Preference Following Bariatric Surgery?
por: Nielsen, Mette S., et al.
Publicado: (2021)

The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial
por: Mitchell, James L, et al.
Publicado: (2023)

CREBH Improves Diet-Induced Obesity, Insulin Resistance, and Metabolic Disturbances by FGF21-Dependent and FGF21-Independent Mechanisms
por: Satoh, Aoi, et al.
Publicado: (2020)

The Antiresorptive Effect of GIP, But Not GLP‐2, Is Preserved in Patients With Hypoparathyroidism—A Randomized Crossover Study
por: Skov‐Jeppesen, Kirsa, et al.
Publicado: (2021)

Editorial: Understanding the Heterogeneity in Exercise-Induced Changes in Glucose Metabolism to Help Optimize Treatment Outcomes
por: Solomon, Thomas P. J., et al.
Publicado: (2021)

Novel Insights into the Cardio-Protective Effects of FGF21 in Lean and Obese Rat Hearts
por: Patel, Vanlata, et al.
Publicado: (2014)

Clinical Trial Highlights – GLP-1 agonists
por: McFarthing, Kevin, et al.
Publicado: (2020)

Is Lean Management implementable in a department of radiology?
por: Karstoft, Jens, et al.
Publicado: (2011)

Hormone Resistance in Diabetes and Obesity: Insulin, Leptin, and FGF21
por: Flier, Jeffrey S.
Publicado: (2012)

FGF21 gene therapy as treatment for obesity and insulin resistance
por: Jimenez, Veronica, et al.
Publicado: (2018)

Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor‐Induced Osteomalacia
por: Hartley, Iris R., et al.
Publicado: (2022)

Propofol Improved Glucose Tolerance Associated with Increased FGF-21 and GLP-1 Production in Male Sprague-Dawley Rats
por: Wu, Chih-Cheng, et al.
Publicado: (2020)

A novel GLP-1 and FGF21 dual agonist has therapeutic potential for diabetes and non-alcoholic steatohepatitis
por: Pan, Qi, et al.
Publicado: (2021)

Muscle mitochondrial stress adaptation operates independently of endogenous FGF21 action
por: Ost, Mario, et al.
Publicado: (2015)

Estradiol-dependent and independent effects of FGF21 in obese female mice
por: Jakovleva, T.V., et al.
Publicado: (2022)

FGF19 subfamily members: FGF19 and FGF21
por: Dolegowska, Katarzyna, et al.
Publicado: (2019)

The Effect of Metformin on Self-Selected Exercise Intensity in Healthy, Lean Males: A Randomized, Crossover, Counterbalanced Trial
por: Pilmark, Nanna Skytt, et al.
Publicado: (2021)

Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans
por: Hansen, Jakob Schiøler, et al.
Publicado: (2015)

Experimental Hyperglycemia Alters Circulating Concentrations and Renal Clearance of Oxidative and Advanced Glycation End Products in Healthy Obese Humans
por: Perkins, Ryan K., et al.
Publicado: (2019)

Managing the complexity of communication: regulation of gap junctions by post-translational modification
por: Axelsen, Lene N., et al.
Publicado: (2013)

The Effects of Free-Living Interval-Walking Training on Glycemic Control, Body Composition, and Physical Fitness in Type 2 Diabetic Patients: A randomized, controlled trial
por: Karstoft, Kristian, et al.
Publicado: (2013)

A pyrexic effect of FGF21 independent of energy expenditure and UCP1
por: Zouhar, Petr, et al.
Publicado: (2021)

FGF21 regulates insulin sensitivity following long-term chronic stress
por: Jelenik, Tomas, et al.
Publicado: (2018)

FGF19 and FGF21: In NASH we trust
por: Talukdar, Saswata, et al.
Publicado: (2020)

Sustained release of a GLP-1 and FGF21 dual agonist from an injectable depot protects mice from obesity and hyperglycemia
por: Gilroy, C. A., et al.
Publicado: (2020)

Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear
por: Rini, Christopher James, et al.
Publicado: (2015)

Raised FGF-21 and Triglycerides Accompany Increased Energy Intake Driven by Protein Leverage in Lean, Healthy Individuals: A Randomised Trial
por: Gosby, Alison K., et al.
Publicado: (2016)

Beta-aminoisobutyric acid is released by contracting human skeletal muscle and lowers insulin release from INS-1 832/3 cells by mediating mitochondrial energy metabolism
por: Barlow, Jonathan P., et al.
Publicado: (2020)

FGF21 and Cardiac Physiopathology
por: Planavila, Anna, et al.
Publicado: (2015)

Fundamentals of FGF19 & FGF21 Action In Vitro and In Vivo
por: Adams, Andrew C., et al.
Publicado: (2012)

Digenic Variants in the FGF21 Signaling Pathway Associated with Severe Insulin Resistance and Pseudoacromegaly
por: Stone, Stephen I, et al.
Publicado: (2020)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
por: Henriksson, Emma, et al.
Publicado: (2020)

Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue
por: Villarroya, Joan, et al.
Publicado: (2018)

Chronic activation of PPARα with fenofibrate reduces autophagic proteins in the liver of mice independent of FGF21
por: Jo, Eunjung, et al.
Publicado: (2017)

Fibroblast Growth Factor 21 (FGF21) in Human Cerebrospinal Fluid: Relationship With Plasma FGF21 and Body Adiposity
por: Tan, Bee K., et al.
Publicado: (2011)

LPS infusion suppresses serum FGF21 levels in healthy adult volunteers
por: Lauritzen, Esben S, et al.
Publicado: (2017)

FGF21 as a Stress Hormone: The Roles of FGF21 in Stress Adaptation and the Treatment of Metabolic Diseases
por: Kim, Kook Hwan, et al.
Publicado: (2014)

Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice
por: Xue, Binghua, et al.
Publicado: (2021)

Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms
por: Sostre-Colón, Jaimarie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jcabggplh3i8t6g1en11qmbc24